INTL GEMOLOGICAL INST Latest Share Price (IGIL)
TODAY IN ONE LINE
IGIL is little changed at ₹407.40 on above-average volume (1.7x avg) — a quiet consolidation day.
With a market cap of ₹17,666.69 Cr., it trades at a P/E of 26.55. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
INTL GEMOLOGICAL INST flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 28.4% YoY
- ●High Capital EfficiencyROCE of 23.3% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 23.1%
- ●Healthy Operating MarginsOPM is structurally strong at 76.3%
- ●High Promoter HoldingPromoters hold 76.5% skin-in-the-game
- ●Steady Dividend YieldReliable 1.24% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest INTL GEMOLOGICAL INST News
What changed recently?
Recent events, corporate actions, and announcements.
INTL GEMOLOGICAL INST valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for INTL GEMOLOGICAL INST, framed against the sector median so the premium or discount is obvious at a glance.
INTL GEMOLOGICAL INST trades at a P/E of 26.55× and P/B of 10.09×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
INTL GEMOLOGICAL INST technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for INTL GEMOLOGICAL INST — derived from the latest tape, not yesterday's close.
INTL GEMOLOGICAL INST last traded at ₹407.4 with an intraday range of ₹400.55–₹417 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹407.40| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 448.98 | +41.58 | +10.21% |
| R3 | 432.53 | +25.13 | +6.17% |
| R2 | 424.77 | +17.37 | +4.26% |
| R1 | 416.08 | +8.68 | +2.13% |
| PIVOT | 408.32 | 0.92 | 0.23% |
| CURRENT | 407.40 | — | — |
| S1 | 399.63 | -7.77 | -1.91% |
| S2 | 391.87 | -15.53 | -3.81% |
| S3 | 383.18 | -24.22 | -5.94% |
| S4 | 366.73 | -40.67 | -9.98% |
IGIL is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹400.55–₹411.85
Trading Inside opening range
INTL GEMOLOGICAL INST financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for INTL GEMOLOGICAL INST — consolidated or standalone — with margins, YoY growth and key ratios inline.
INTL GEMOLOGICAL INST reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹17,666.69 Cr. and reported EPS of ₹4.30.
| Metric | Dec 2025 | Jan 2026 |
|---|---|---|
| Revenue from Operations | 1,229 | 1,229 ▲ 0.0% |
| Sales Growth YoY %Derived | 16.71% | — |
| Other Income | 46 | 46 ▲ 0.0% |
| Total Income | 1,275 | 1,275 ▲ 0.0% |
| -2 | -2 ▲ 0.0% | |
| Gross ProfitDerived | 1,231 | 1,231 ▲ 0.0% |
| Gross Margin %Derived | 100.14% | 100.14% |
| 494 | 494 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 737 | 737 ▲ 0.0% |
| OPM %Derived | 59.94% | 59.94% |
| 53 | 53 ▲ 0.0% | |
| Profit Before Tax (PBT) | 730 | 730 ▲ 0.0% |
| 199 | 199 ▲ 0.0% | |
| Effective Tax %Derived | 27.19% | 27.19% |
| Total Profit for Period | 532 | 532 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 532 | 532 ▲ 0.0% |
| Net Profit Margin %Derived | 43.25% | 43.25% |
| PAT Growth YoY %Derived | 24.41% | — |
| Earnings Per Share (EPS ₹) | 12.30 | 12.30 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 43 | 43 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 24 | 24 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 545 | 545 ▲ 0.0% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 22.74% | 22.74% |
| Other Cost % of RevenueDerived | 17.46% | 17.46% |
| Interest Coverage (x)Derived | 71.14x | 71.14x |
| Period | Dec 2024 | Mar 2025 | Dec 2025 | Jan 2026 | Trend |
|---|---|---|---|---|---|
| Revenue from Operations | 1,053 | 1,053 ▲ 0.0% | 1,229 ▲ 16.7% | 1,229 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 16.71% | — | |
| Other Income | 35 | 35 ▲ 0.0% | 46 ▲ 30.2% | 46 ▲ 0.0% | |
| Total Income | 1,088 | 1,088 ▲ 0.0% | 1,275 ▲ 17.1% | 1,275 ▲ 0.0% | |
4 | 4 ▲ 0.0% | -2 ▼ 147.3% | -2 ▲ 0.0% | ||
| Gross ProfitDerived | 1,049 | 1,049 ▲ 0.0% | 1,231 ▲ 17.3% | 1,231 ▲ 0.0% | |
| Gross Margin %Derived | 99.64% | 99.64% | 100.14% | 100.14% | |
450 | 450 ▲ 0.0% | 494 ▲ 9.9% | 494 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 600 | 600 ▲ 0.0% | 737 ▲ 22.8% | 737 ▲ 0.0% | |
| OPM %Derived | 56.94% | 56.94% | 59.94% | 59.94% | |
50 | 50 ▲ 0.0% | 53 ▲ 5.7% | 53 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 585 | 585 ▲ 0.0% | 730 ▲ 24.7% | 730 ▲ 0.0% | |
158 | 158 ▲ 0.0% | 199 ▲ 25.6% | 199 ▲ 0.0% | ||
| Effective Tax %Derived | 27.00% | 27.00% | 27.19% | 27.19% | |
| Total Profit for Period | 427 | 427 ▲ 0.0% | 532 ▲ 24.4% | 532 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 427 | 427 ▲ 0.0% | 532 ▲ 24.4% | 532 ▲ 0.0% | |
| Net Profit Margin %Derived | 40.57% | 40.57% | 43.25% | 43.25% | |
| PAT Growth YoY %Derived | — | — | 24.41% | — | |
| Earnings Per Share (EPS ₹) | 9.89 | 9.89 ▲ 0.0% | 12.30 ▲ 24.4% | 12.30 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 43 | 43 ▲ 0.0% | 43 ▲ 0.0% | 43 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 6 | 6 ▲ 0.0% | 24 ▲ 273.2% | 24 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 503 | 503 ▲ 0.0% | 545 ▲ 8.3% | 545 ▲ 0.0% | |
| Material Cost % of RevenueDerived | — | — | — | — | |
| Employee Cost % of RevenueDerived | 25.17% | 25.17% | 22.74% | 22.74% | |
| Other Cost % of RevenueDerived | 17.53% | 17.53% | 17.46% | 17.46% | |
| Interest Coverage (x)Derived | 67.54x | 67.54x | 71.14x | 71.14x |
INTL GEMOLOGICAL INST segment analysis : revenue and profit mix.
Disclosed business segments at INTL GEMOLOGICAL INST with their share of revenue and profit, switchable between consolidated and standalone reporting.
INTL GEMOLOGICAL INST discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for INTL GEMOLOGICAL INST.
Our AI distills the core fundamental drivers supporting INTL GEMOLOGICAL INST, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
INTL GEMOLOGICAL INST's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 53.01% far exceeds industry peers; structural cost advantage evident.
ROCE 23.33% and ROE 23.06% demonstrate superior capital efficiency and returns.
Zero debt (D/E 0.0000x) indicates fortress-like balance sheet with minimal leverage.
TTM revenue growth 20.90% and latest quarterly EPS growth 27.60% YoY show momentum.
High institutional ownership with FII holdings at 10.55% signals strong investor confidence.
Key Risks.
Latest quarterly sales declined 87.04% YoY; significant revenue contraction despite profit growth.
Latest quarterly profit declined 89.28% YoY; earnings volatility raises sustainability concerns.
Price unchanged over 52-week period; zero return limits shareholder value creation.
Limited trading history since 2024 IPO creates valuation uncertainty and historical gaps.
Beta 1.36 indicates moderate systematic volatility relative to broader market movements.
Flip Conditions.
Valuation risk. a P/E above 35 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 18% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.62%.
INTL GEMOLOGICAL INST peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — INTL GEMOLOGICAL INST is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
INTL GEMOLOGICAL INST chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for INTL GEMOLOGICAL INST — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
INTL GEMOLOGICAL INST delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for INTL GEMOLOGICAL INST over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in INTL GEMOLOGICAL INST stood at 48.3% of traded volume, against a 20-day average of 48.4%.
INTL GEMOLOGICAL INST announcements: results, concalls, ratings, M&A.
Filings INTL GEMOLOGICAL INST sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
INTL GEMOLOGICAL INST files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 153 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
International Gemological Institute Limited has informed the Exchange about Transcript
Copy of Newspaper Publication
International Gemological Institute Limited has informed the Exchange about Copy of Newspaper Publication.
Analysts/Institutional Investor Meet/Con. Call Updates
International Gemological Institute Limited has informed the Exchange about Link of Recording
Monitoring Agency Report
Pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we…
Press Release
International Gemological Institute Limited has informed the Exchange regarding a press release dated October 21, 2026, titled "Press Release".
Investor decks & rating reports.
INTL GEMOLOGICAL INST dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue INTL GEMOLOGICAL INST has declared, sequenced by announce and record date.
INTL GEMOLOGICAL INST corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
INTL GEMOLOGICAL INST insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in INTL GEMOLOGICAL INST as reported to SEBI — buying and selling signals from the people who know the business best.
INTL GEMOLOGICAL INST insider activity below tracks 1 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Aniket Shah | Insider | 20 Dec 2024 | buy | +2.0 K | ₹10.24 L | ₹504.48 |
About INTL GEMOLOGICAL INST: business, sector, key facts.
What INTL GEMOLOGICAL INST does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
INTL GEMOLOGICAL INST operates in the Diversified Commercial Services industry under the Services sector, listed as NSE: IGIL, BSE: 544311.
International Gemmological Institute (India) Limited (IGIL) is a leading provider of certification and accreditation services for gemstones and jewelry. Their primary business revolves around assessing the quality and authenticity of various gems and precious materials, ensuring transparency and trust within the industry. This includes a comprehensive range of services encompassing natural and laboratory-grown diamonds, colored gemstones, and studded jewelry. Their expertise allows them to verify the quality and characteristics of these items, providing critical information for buyers, sellers, and insurers.
A significant aspect of IGIL's operations lies in their diamond screening and sorting capabilities. This process involves meticulously examining diamonds to determine their quality parameters such as carat weight, clarity, cut, and color. This detailed evaluation helps to categorize diamonds and assess their value, which is crucial for market transactions and fair pricing. This value-added service adds significant value for clients seeking to understand their diamond assets more accurately.
Beyond certification, IGIL actively contributes to the education and professional development within the gemmology field. They operate IGI Schools of Gemology, offering a range of courses and programs designed to train aspiring gemologists and enhance the skills of existing professionals. These educational initiatives are vital in maintaining high standards within the industry and nurturing a skilled workforce capable of handling the complexities of gemstone evaluation and trade.
IGIL's services extend beyond the Indian market, indicating a global reach and recognition of their expertise. Their international presence signifies their commitment to upholding industry standards on a wider scale, promoting fairness and transparency in the global gemstone and jewelry trade. The company's long history, established in 1975, demonstrates a sustained commitment to the industry and its evolving needs.
In summary, IGIL operates a multifaceted business focused on certification, education, and value-added services within the gemstone and jewelry sector. Their expertise in gemmology, combined with their educational initiatives, positions them as a key player in maintaining industry standards and fostering growth within the global market. The company's international presence further solidifies its role as a trusted authority in the field.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AARVI ENCON (AARVI) Share PricePeer
- ABMINTLLTD (ABMINTLLTD) Share PricePeer
- ACCURACY SHIPPING (ACCURACY) Share PricePeer
- ACE INTEGRATED SOLU (ACEINTEG) Share PricePeer
- ACLGATI (ACLGATI) Share PricePeer
- Stocks near 52-week high (breakout watch)Screener
- Breakout Trader strategy playbookStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about INTL GEMOLOGICAL INST (IGIL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of INTL GEMOLOGICAL INST (IGIL)?
The current share price of INTL GEMOLOGICAL INST (IGIL) is ₹407.40. Today, the stock has gained by ₹0.45 (0.11%), trading in a range of ₹400.55 to ₹417.00. The stock opened at ₹406.95 with a trading volume of 10,24,398 shares.
02Is INTL GEMOLOGICAL INST stock a good investment for long-term?
INTL GEMOLOGICAL INST can be considered for long-term investment based on several factors. The company has a market capitalization of ₹17,666.69 Cr., P/E ratio of 26.55, ROE of 23.06%, and ROCE of 23.33%. The dividend yield stands at 1.24%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of INTL GEMOLOGICAL INST stock?
The 52-week high price of INTL GEMOLOGICAL INST (IGIL) is ₹420.60, while the 52-week low is ₹287.00. Currently trading at ₹407.40, the stock is 41.95% above its 52-week low and 3.14% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy INTL GEMOLOGICAL INST stock at the current price?
Whether to buy INTL GEMOLOGICAL INST stock at ₹407.40 depends on multiple factors. The stock is currently trading with a P/E ratio of 26.55 and P/B ratio of 10.09. Today's performance shows a gain of 0.11%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of INTL GEMOLOGICAL INST and when is the next dividend?
INTL GEMOLOGICAL INST offers a dividend yield of 1.24%, which means for every ₹100 invested at the current price of ₹407.40, you can expect to receive approximately ₹1.24 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of INTL GEMOLOGICAL INST?
INTL GEMOLOGICAL INST's key financial metrics include: P/E Ratio: 26.55, P/B Ratio: 10.09, ROE: 23.06%, ROCE: 23.33%, Dividend Yield: 1.24%, EPS: ₹4.30, Book Value: ₹32.62, and Debt-to-Equity: 0. The company's market cap stands at ₹17,666.69 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is INTL GEMOLOGICAL INST stock performing today in the market?
INTL GEMOLOGICAL INST stock opened at ₹406.95 and is currently trading at ₹407.40, showing a gain of ₹0.45 (0.11%). The intraday high is ₹417.00 and low is ₹400.55. The trading volume stands at 10,24,398 shares, indicating strong market participation today.
08What is the P/E ratio of INTL GEMOLOGICAL INST and what does it indicate?
INTL GEMOLOGICAL INST has a Price-to-Earnings (P/E) ratio of 26.55, which means investors are willing to pay 26.55 for every ₹1 of earnings. With an EPS of ₹4.30, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about INTL GEMOLOGICAL INST (IGIL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.